28. 全身性アミロイドーシス Systemic amyloidosis Clinical trials / Disease details

臨床試験数 : 267 / 薬物数 : 241 - (DrugBank : 77) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 180

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04504825 (ClinicalTrials.gov)	February 2, 2021	20/7/2020	A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloido ...	A Phase 3, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of CAEL-101 and Plasm ...	AL Amyloidosis	Drug: CAEL-101;Other: Placebo;Drug: cyclophosphamide , bortezomib, and Dexamethasone (CyBorD) regimen ...	Alexion	NULL	Recruiting	18 Years	N/A	All	124	Phase 3	United States;Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Germany;Greece;Israel;Italy;Jap ...
2	NCT04512235 (ClinicalTrials.gov)	November 12, 2020	10/8/2020	A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloido ...	A Phase 3, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of CAEL-101 and Plasm ...	AL Amyloidosis	Drug: CAEL-101;Other: Placebo;Drug: cyclophosphamide , bortezomib, and dexamethasone (CyBorD) regimen ...	Alexion	NULL	Recruiting	18 Years	N/A	All	267	Phase 3	United States;Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Germany;Greece;Israel;Italy;Jap ...

First Previous1Next Last